Literature DB >> 7940430

Clinical significance of upper airway dysfunction in motor neurone disease.

E García-Pachón1, J Martí, M Mayos, P Casan, J Sanchis.   

Abstract

BACKGROUND: To assess the occurrence, functional characteristics and prognostic value of upper airway dysfunction in motor neurone disease, 27 patients unselected for respiratory symptoms were studied.
METHODS: Upper airway function was evaluated by analysis of the maximal flow-volume loop. Neurological diagnosis was established from the clinical history and physical examination. The degree of impairment was quantified by the Appel score.
RESULTS: Twelve patients (group A) showed abnormalities of the maximal flow-volume loop consistent with flow limitation (seven patients) or instability of upper airway function (gross oscillations of airflow, five patients). The remaining 15 patients (group B) exhibited a normal or generally reduced maximal flow-volume loop, suggestive of muscle weakness. No differences were observed between groups in general physical condition, rate of disease progression, or duration of disease.
CONCLUSIONS: Upper airway dysfunction in patients with motor neurone disease was a frequent finding. It was present more often, but not exclusively, in patients with bulbar features and was unrelated to prognosis.

Entities:  

Mesh:

Year:  1994        PMID: 7940430      PMCID: PMC475187          DOI: 10.1136/thx.49.9.896

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  DYNAMIC SPIROMETRY IN PATIENTS WITH TRACHEAL STENOSIS.

Authors:  H ENGSTROEM; G GRIMBY; B SOEDERHOLM
Journal:  Acta Med Scand       Date:  1964-09

Review 2.  Flow oscillations on the flow-volume loop: clinical and physiological implications.

Authors:  W G Vincken; M G Cosio
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

3.  A rating scale for amyotrophic lateral sclerosis: description and preliminary experience.

Authors:  V Appel; S S Stewart; G Smith; S H Appel
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

4.  Spirometric reference values from a Mediterranean population.

Authors:  J Roca; J Sanchis; A Agusti-Vidal; F Segarra; D Navajas; R Rodriguez-Roisin; P Casan; S Sans
Journal:  Bull Eur Physiopathol Respir       Date:  1986 May-Jun

5.  Upper airways obstruction with bilateral vocal cord paralysis.

Authors:  Y Cormier; H Kashima; W Summer; H Menkes
Journal:  Chest       Date:  1979-04       Impact factor: 9.410

6.  A comparison of maximum inspiratory and expiratory flow in health and in lung disease.

Authors:  J Jordanoglou; N B Pride
Journal:  Thorax       Date:  1968-01       Impact factor: 9.139

7.  Upper airway function in burn patients. Correlation of flow-volume curves and nasopharyngoscopy.

Authors:  E F Haponik; A M Munster; R A Wise; P L Smith; D A Meyers; E J Britt; E R Bleecker
Journal:  Am Rev Respir Dis       Date:  1984-02

8.  Respiratory muscle function and ventilatory control. I in patients with motor neurone disease. II in patients with myotonic dystrophy.

Authors:  D E Serisier; F L Mastaglia; G J Gibson
Journal:  Q J Med       Date:  1982

9.  Detection of upper airway muscle involvement in neuromuscular disorders using the flow-volume loop.

Authors:  W Vincken; G Elleker; M G Cosio
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

10.  Flow oscillations on the flow-volume loop: a nonspecific indicator of upper airway dysfunction.

Authors:  W Vincken; M G Cosio
Journal:  Bull Eur Physiopathol Respir       Date:  1985 Nov-Dec
View more
  3 in total

Review 1.  Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease.

Authors:  M I Polkey; R A Lyall; A C Davidson; P N Leigh; J Moxham
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Disorders of Sleep and Breathing during Sleep in Neuromuscular Disease.

Authors:  Erik Van Lunteren; Henry J. Kaminski
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

3.  Motor neurone disease.

Authors:  J M Shneerson
Journal:  BMJ       Date:  1996-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.